Natural killer cells and cancer.

作者: Jun Wu , Lewis L Lanier

DOI: 10.1016/S0065-230X(03)90004-2

关键词: NK-92Interleukin 12Natural killer T cellCell biologyAntigen-presenting cellMyeloid-derived Suppressor CellLymphokine-activated killer cellInterleukin 21BiologyAntigen presentation

摘要: Natural killer (NK) cells are lymphocytes that were first identified for their ability to kill tumor without deliberate immunization or activation. Subsequently, they also found be able infected with certain viruses and attack preferentially lack expression of major histocompatibility complex (MHC) class I antigens. The recent discovery novel NK receptors ligands has uncovered the molecular mechanisms regulate activation function. Several activating cell costimulatory molecules have been permit these recognize tumors virus-infected cells. These modulated by inhibitory sense levels MHC on prospective target prevent unwanted destruction healthy tissues. In vitro in vivo, cytotoxic can enhanced cytokines, such as interleukin (IL)-2, IL-12, IL-15 interferon alpha/beta (IFN-alpha/beta). animal studies, shown play a critical role control growth metastasis provide innate immunity against infection viruses. Following activation, release cytokines chemokines induce inflammatory responses; modulate monocyte, dendritic cells, granulocyte differentiation; influence subsequent adaptive immune responses. underlining mechanism discriminating normal provided new insights into immunosurveillance suggested strategies treatment human cancer.

参考文章(211)
Lewis L. Lanier, On guard--activating NK cell receptors. Nature Immunology. ,vol. 2, pp. 23- 27 ,(2001) , 10.1038/83130
L L Lanier, C Chang, S Lazetic, J P Houchins, J H Phillips, Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. Journal of Immunology. ,vol. 157, pp. 4741- 4745 ,(1996)
Henning Walczak, Robert E. Miller, Kiley Ariail, Brian Gliniak, Thomas S. Griffith, Marek Kubin, Wilson Chin, Jon Jones, Anne Woodward, Tiep Le, Craig Smith, Pam Smolak, Raymond G. Goodwin, Charles T. Rauch, JoAnn C.L. Schuh, David H. Lynch, Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nature Medicine. ,vol. 5, pp. 157- 163 ,(1999) , 10.1038/5517
Derry Roopenian, Greg Christianson, Subramaniam Malarkannan, Patty P. Shih, Aamir R. Zuberi, Tiffany Horng, Nilabh Shastri, Peter A. Eden, The Molecular and Functional Characterization of a Dominant Minor H Antigen, H60 Journal of Immunology. ,vol. 161, pp. 3501- 3509 ,(1998)
B. A. Garni-Wagner, E. Stoneman, A. Takashima, Vinay Kumar, K. Land, P. A. Mathew, M. Bennett, Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. Journal of Immunology. ,vol. 151, pp. 5328- 5337 ,(1993)
Hideo Yagita, Hisaya Akiba, Nobuhiko Kayagaki, Haruki Okamura, Kenji Nakanishi, Hiroko Tsutsui, Ko Okumura, Masafumi Nakayama, Noriko Yamaguchi, Kazuyoshi Takeda, Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. Journal of Immunology. ,vol. 163, pp. 1906- 1913 ,(1999)
J. Sayos, C. Wu, M. Morra, N. Wang, X. Zhang, D. Allen, S. van Schaik, L. Notarangelo, R. Geha, M. G. Roncarolo, H. Oettgen, J. E. De Vries, G. Aversa, C. Terhorst, The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM Nature. ,vol. 395, pp. 462- 469 ,(1998) , 10.1038/26683
Peter Hersey, Xu Dong Zhang, How melanoma cells evade trail-induced apoptosis Nature Reviews Cancer. ,vol. 1, pp. 142- 150 ,(2001) , 10.1038/35101078
V Fanning, S Starr, B Perussia, S Abraham, G Trinchieri, Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1 Journal of Immunology. ,vol. 130, pp. 2133- 2141 ,(1983)
Lewis L. Lanier, A renaissance for the tumor immunosurveillance hypothesis Nature Medicine. ,vol. 7, pp. 1178- 1180 ,(2001) , 10.1038/NM1101-1178